Trials / Unknown
UnknownNCT02753543
Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma
A Multi-center, Prospective, Single-arm, Open Label Phase II Study of Chidamide Combined With Chemotherapy in the Treatment of Peripheral T Cell Lymphoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm, prospective trial to evaluate the efficacy and safety of Chidamide in combination with previous chemotherapy in peripheral T cell lymphoma patients who did not achieve complete response after 3 cycles of chemotherapy in interim evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chidamide |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-11-01
- Completion
- 2019-11-01
- First posted
- 2016-04-28
- Last updated
- 2017-11-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02753543. Inclusion in this directory is not an endorsement.